10-Q: Ethema Health Reports Q3 Profit Amidst Acquisitions, Liquidity Concerns Persist

Ethema Health Corporation reported a net income of $66,136 for Q3 2025, driven by significant revenue growth from recent acquisitions, despite ongoing liquidity challenges and a substantial accumulated deficit.

Summary

• Revenues for the three months ended September 30, 2025, increased by 214.2% to $5,529,402, up from $1,760,000 in the prior year, primarily due to the acquisition of Edgewater Recovery Centers, LLC (ERC).
• Nine-month revenues increased by 206.6% to $13,952,597, compared to $4,550,200 in the same period last year, with $7,835,447 attributed to the ERC acquisition.
• Operating income for Q3 2025 was $546,015, a significant improvement from an operating loss of $(723,708) in Q3 2024.
• Net income for Q3 2025 was $66,136, a substantial improvement from a net loss of $(1,000,714) in Q3 2024.
• For the nine months ended September 30, 2025, the company reported a net loss of $(1,114,490), an improvement from a net loss of $(1,840,192) in the prior year.
• The company completed the acquisition of Edgewater Recovery Centers, LLC (ERC) on January 9, 2025, expanding its addiction treatment operations into Morehead and Paducah, Kentucky.
• As of September 30, 2025, the company had a working capital deficiency of $12.2 million and total liabilities exceeding total assets by $8.6 million, raising substantial doubt about its ability to continue as a going concern.
• Disclosure controls and procedures were deemed not effective as of September 30, 2025, due to a lack of written policies and procedures for all material transactions.
• The company entered into an exclusive Letter of Intent on October 20, 2025, to acquire additional assets and entities under the Addiction Recovery Care LLC (ARC) brand name in Kentucky, with plans to create a new entity (NewcoARIA) for a potential IPO.
• Cash balance as of September 30, 2025, was $114,030, down from $244,771 at December 31, 2024.

Sentiment

Score: 3

Explanation: While the company achieved a quarterly net income and significant revenue growth, these positives are heavily overshadowed by severe liquidity issues, a substantial accumulated deficit, a going concern warning, ineffective internal controls, and numerous defaulted debt obligations. The strategic acquisition plans are ambitious but require significant capital, adding to the financial uncertainty. The overall financial health remains precarious.

Positives

• Achieved a net income of $66,136 for the three months ended September 30, 2025, a significant turnaround from a $1,000,714 net loss in the prior year's quarter.
• Reported substantial revenue growth of 214.2% for Q3 2025 and 206.6% for the nine months ended September 30, 2025, largely driven by the acquisition of Edgewater Recovery Centers, LLC.
• Operating income for Q3 2025 was $546,015, a considerable improvement from an operating loss of $(723,708) in Q3 2024, indicating improved operational efficiency or scale.
• Organic revenue growth from existing operations (excluding ERC acquisition) increased by 41.8% for Q3 2025 and 34.4% for the nine months ended September 30, 2025, primarily due to increased patient count at the West Palm Beach facility and the Boca Raton facility becoming fully operational.
• The acquisition of Edgewater Recovery Centers, LLC on January 9, 2025, significantly expanded the company's footprint and service offerings in Kentucky.
• Entered into an exclusive Letter of Intent to acquire substantial assets and entities from Addiction Recovery Care LLC, indicating aggressive strategic expansion plans and potential for future growth and a new entity IPO.

Negatives

• Maintains a significant accumulated deficit of $45.5 million as of September 30, 2025.
• Reports a working capital deficiency of $12.2 million and total liabilities exceeding total assets by $8.6 million, raising substantial doubt about its ability to continue as a going concern.
• Cash balance is critically low at $114,030 as of September 30, 2025, down from $244,771 at December 31, 2024.
• Disclosure controls and procedures were concluded to be not effective as of September 30, 2025, due to a lack of written policies and procedures.
• Several short-term convertible notes and funding arrangements are in default or require renegotiation, including the Auctus Fund, LLC note (matured May 7, 2020), Joshua Bauman note (matured August 9, 2024), and Series R promissory notes (matured March 31, 2025).
• Interest expense increased significantly by 107.7% for Q3 2025 and 162.7% for the nine months ended September 30, 2025, largely due to new debt from acquisitions and default interest.

Risks

• Substantial doubt about the ability to continue as a going concern due to an accumulated deficit of $45.5 million, a working capital deficiency of $12.2 million, and total liabilities exceeding total assets by $8.6 million.
• Dependence on raising additional capital through equity or debt financing, with no assurance of success, which could lead to significant shareholder dilution or restrictive debt covenants.
• Ineffective disclosure controls and procedures, indicating potential weaknesses in financial reporting and internal controls.
• High exposure to interest rate risk on various bank loans, assumed debt, convertible debt, promissory notes, short-term loans, and funding arrangements.
• Concentration of revenue from a group of commercial healthcare insurers, making the company vulnerable to adverse changes in their policies towards substance abuse patients.
• Potential for material adverse effects from legal disputes, although currently none are believed to be material.
• Reliance on related party transactions for real property leases and financing, which may present conflicts of interest or less favorable terms than arm's-length transactions.
• Uncertainty regarding the repayment or conversion of various short-term and convertible notes, many of which are currently in default or require renegotiation.

Future Outlook

The company plans to continue growing its rehabilitation and detox business organically and through acquisitions over the next twelve months. It is actively exploring additional treatment center options and patient sources nationwide. A significant strategic move involves an exclusive Letter of Intent to acquire assets and entities from Addiction Recovery Care LLC in Kentucky, with plans to create a new entity, NewcoARIA, which would consolidate existing and acquired treatment entities and potentially pursue an Initial Public Offering on a senior U.S. exchange. The company anticipates requiring approximately $1.5 million in working capital over the next twelve months and will be dependent on raising additional capital through equity or debt financing.

Management Comments

• Management believes that current available resources will not be sufficient to fund planned expenditures over the next 12 months.
• The company will be dependent upon the raising of additional capital through placement of common shares, and/or debt financing in order to implement its business plan and generate sufficient revenue in excess of costs.
• Management does not expect that disclosure controls and procedures and internal control processes, even if improved, will prevent all error and all fraud.

Industry Context

Ethema Health Corporation operates in the addiction treatment sector, a growing but competitive industry. The company's strategy of acquiring existing treatment centers, such as Edgewater Recovery Centers and the proposed Addiction Recovery Care LLC assets, aligns with a trend of consolidation and expansion to achieve scale and broader geographical reach. The focus on both Florida and Kentucky indicates a regional growth strategy. However, the industry is also subject to complex regulatory environments, reliance on commercial insurers, and significant capital requirements for expansion, which Ethema's financial position highlights as a challenge.

Comparison to Industry Standards

• The significant revenue growth (over 200% year-over-year for Q3 and YTD) is robust, but largely acquisition-driven. Organic growth of 34.4% to 41.8% is also strong, suggesting effective patient acquisition and retention in existing facilities.
• The shift from operating loss to operating income in Q3 2025 is a positive operational indicator, potentially reflecting improved economies of scale post-acquisition, which could be a competitive advantage if sustained.
• The company's accumulated deficit of $45.5 million and working capital deficiency of $12.2 million are substantially worse than industry benchmarks for healthy, growing companies, indicating severe financial distress.
• The reliance on related party financing and the number of defaulted or renegotiated debt instruments suggest a higher cost of capital and limited access to traditional financing compared to industry peers with stronger balance sheets.
• The disclosure of ineffective internal controls is a significant governance concern, contrasting with the robust control environments expected of publicly traded companies in the healthcare sector.

Corporate Governance

Legal Proceedings

• Currently not involved in any litigation believed to have a material adverse effect on financial condition or results of operations.

Related Party Transactions

• BH Properties Fund LLC, controlled by CEO Shawn Leon, acquired real property associated with Edgewater Recovery Centers' operations and subsequently leased it to ARIA Kentucky LLC on an arms-length basis at market rates.
• The company entered into 7 lease agreements, effective January 1, 2025, and 2 additional lease agreements, effective July 1, 2025, with BH Properties and its subsidiary Viking Assets, LLC (related parties), totaling $1,206,000 in annual base rent.
• Eileen Greene, spouse of CEO Shawn Leon, advanced the company $250,000 on July 4, 2024, with an original issue discount of $35,000. Repayments were paused, and the balance outstanding was $273,461 as of September 30, 2025.
• Shawn E. Leon converted $1,500,000 of related party payables into 3,000,000,000 common shares on July 12, 2024, and $6,000 into 600,000 Series A Preferred stock on September 27, 2024.
• Eileen Greene converted $500,000 of related party payables into 1,000,000,000 common shares on July 12, 2024.
• Shawn E. Leon earned management fees of $180,000 during the nine months ended September 30, 2025.
• Liabilities owed to ERC Investments, LLC, New Journey, LLC, and JDE Properties, LLC (all acquired by BH Properties, controlled by CEO Shawn Leon) were assumed by the company as part of the Edgewater acquisition, totaling $783,679, $46,615, and $37,525 respectively.
• The company pays monthly rent to ERC Investments, LLC ($76,000), New Journey, LLC ($5,500), JDE Properties, LLC ($5,000), and Viking Assets, LLC ($14,000) for various properties.
• A charity controlled and managed by Shawn Leon advanced the company $31,000 during the nine months ended September 30, 2025, with $1,200 repaid.
• Note payables to ERC Investments, LLC ($35,624) and New Journey Investments, LLC ($50,393) are outstanding, bearing interest and secured by properties owned by BH Properties and its subsidiaries.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from potential future equity raises to address liquidity and fund acquisitions. The going concern warning indicates a high risk of capital loss. The ineffective disclosure controls also pose a risk to transparency and investor confidence.
• **Employees**: The expansion through acquisitions (Edgewater, potential ARC) suggests job growth and stability in the acquired operations, but the overall financial instability could pose long-term risks.
• **Customers (Patients)**: Expansion of facilities and services could improve access to addiction treatment, but financial instability could impact service quality or continuity if not managed effectively.
• **Suppliers/Creditors**: High liquidity risk, working capital deficiency, and defaulted debt obligations indicate a heightened risk of delayed or non-payment. Related party creditors may have different repayment terms or priorities.
• **Regulatory Authorities**: The ineffective disclosure controls and the going concern warning will likely draw increased scrutiny from the SEC and other regulatory bodies.

Next Steps

• Continue to grow the rehabilitation and detox business organically.
• Pursue additional acquisitions in the addiction treatment sector.
• Explore other treatment center options and sources of patients throughout the country.
• Finalize the acquisition of assets and separate entities from Addiction Recovery Care LLC (ARC) in Kentucky.
• Create a new entity, NewcoARIA, to hold existing and acquired treatment entities.
• Potentially pursue an Initial Public Offering (IPO) of NewcoARIA on a senior U.S. exchange.
• Raise approximately $1.5 million in working capital over the next twelve months through equity or debt financing.
• Improve disclosure controls and procedures by adopting appropriate policies and procedures to address all material transactions and developments impacting financial statements.

Key Dates

Recommendation

Despite a quarterly net income and substantial revenue growth, the company faces severe financial distress, evidenced by a critical cash balance, a $12.2 million working capital deficiency, and an $8.6 million excess of liabilities over assets. The explicit 'going concern' warning, coupled with ineffective disclosure controls and numerous defaulted debt obligations, signals profound operational and financial risks. While strategic acquisitions are planned, the funding mechanisms involve significant dilution and further debt, with no guarantee of success. The current financial position is unsustainable without substantial, high-risk capital infusions. Investors face an extremely high risk of capital impairment.

Keywords

Addiction Treatment, Rehabilitation Services, SEC Filing, 10-Q, Ethema Health Corporation, GRST, Financial Results, Acquisition, Edgewater Recovery Centers, Going Concern, Liquidity, Debt Financing, Healthcare Industry, Corporate Governance, Related Party Transactions, Kentucky Operations, Florida Operations, Quarterly Report